A Polymorphism in MAPKAPK3 Affects Response to Interferon Therapy for Chronic Hepatitis C
To access this article, please choose from the options below
Conflicts of interest The authors disclose no conflicts.
Funding This study was supported by a grant from the Japanese Millennium Project, and in part by Dainippon Sumitomo Pharma Co, Ltd. This work was also supported in part by a Grant-in-Aid for Scientific Research and Development from the Ministry of Education, Sports, Culture, and Technology and the Ministry of Health, Labor, and Welfare.
PII: S0016-5085(09)00165-6
doi:10.1053/j.gastro.2009.01.061
© 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.

